Marking International Clinical Trials Day, we bring you a special Q&A with Andrea Manfrin, Deputy Director of Clinical Trials ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya) for the treatment of Crohn’s ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved polihexanide (Akantior) to treat acanthamoeba keratitis. Acanthamoeba keratitis is an infection of the cornea, the clear ...

A full list of side effects will be included in the Patient Information Leaflet and the Summary of Product Characteristics, available on the MHRA website within 7 days of approval. Dr Sheena ...

A full list of all side effects reported with this medicine is available in the patient information leaflet or from the product information published on the MHRA website. As with any medicine ...

MHRA is once again taking a global lead" says Lord O'Shaughnessy Major progress has been made in delivering a more efficient and adaptable ...

As with all products, we will keep its safety under close review The Medicines and Healthcare products Regulatory Agency ...

The summary of product characteristics and patient information leaflets will be published on the MHRA products website within 7 days of approval. Healthcare professionals are encouraged to report ...

Bengaluru, Karnataka, India, May 27, 2025Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that the Medicines and Healthcare ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple myeloma (MM). This authorisation is said to be a global first for Blenrep ...